STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,000 | -90.5% | 6,969 | -86.0% | 0.00% | – |
| Q2 2021 | $148,000 | +45.1% | 49,839 | +35.4% | 0.00% | – |
| Q1 2021 | $102,000 | +200.0% | 36,807 | +159.0% | 0.00% | – |
| Q4 2020 | $34,000 | -2.9% | 14,212 | -13.8% | 0.00% | – |
| Q3 2020 | $35,000 | -52.7% | 16,478 | -16.8% | 0.00% | – |
| Q2 2020 | $74,000 | +221.7% | 19,797 | +65.0% | 0.00% | – |
| Q1 2020 | $23,000 | -70.1% | 12,001 | -67.6% | 0.00% | – |
| Q4 2019 | $77,000 | +67.4% | 37,077 | +91.5% | 0.00% | – |
| Q3 2019 | $46,000 | -57.4% | 19,359 | -43.9% | 0.00% | – |
| Q2 2019 | $108,000 | -10.0% | 34,519 | +43.2% | 0.00% | – |
| Q1 2019 | $120,000 | +11900.0% | 24,106 | +11601.9% | 0.00% | – |
| Q4 2018 | $1,000 | -99.7% | 206 | -99.7% | 0.00% | – |
| Q3 2018 | $350,000 | +4.5% | 72,240 | +29.5% | 0.00% | – |
| Q2 2018 | $335,000 | +78.2% | 55,771 | +164.2% | 0.00% | – |
| Q1 2018 | $188,000 | +571.4% | 21,109 | +429.8% | 0.00% | – |
| Q4 2017 | $28,000 | +600.0% | 3,984 | +640.5% | 0.00% | – |
| Q3 2017 | $4,000 | – | 538 | +3064.7% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 17 | -99.9% | 0.00% | – |
| Q1 2017 | $73,000 | – | 15,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |